设为首页         

资讯内容 Content

[ESC2011]左主干冠脉病变的治疗选择——Eeckhout 博士专访
国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

作者:Eeckhout 编辑:国际循环网 时间:2011/8/30 16:53:37    加入收藏
 关键字:左主干冠脉病变 SYNTAX CABG PCI TAVI 

    <International Circulation>:  Have we had any new generation of drug-eluting stent platform which will possibly improve the outcome of PCI in treating this group of patients?

  《国际循环》:在这类患者的治疗中,新一代药物洗脱支架平台是否可能改善PCI的结果?

    Dr. Eeckhout: Like I mentioned before, bio-absorbable stent is not any longer just a stent because it is a scaffolding device that disappears over time. This is certainly a key progress. In the meantime, we will see at this congress some reports on the fact that late thrombosis has virtually disappeared with newer generation drug eluting stents. I refer to the everolimus drug eluting stent, the Biolimus A9 that uses the bio-absorbable coating technology, all of these devices in my humble opinion improve the<



上一页  [1]  [2]  [3]  [4]  

 
京ICP备15014970号-5   国际循环 版权所有  2008-2022 icirculation.com  All Rights Reserved